<VariationArchive VariationID="3024167" VariationName="NM_000124.4(ERCC6):c.2321_2322del (p.Lys774fs)" VariationType="Deletion" Accession="VCV003024167" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2024-03-05" MostRecentSubmission="2024-03-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3184423" VariationID="3024167">
      <GeneList>
        <Gene Symbol="ERCC6" FullName="ERCC excision repair 6, chromatin remodeling factor" GeneID="2074" HGNC_ID="HGNC:3438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49434881" stop="49539538" display_start="49434881" display_stop="49539538" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50664490" stop="50747146" display_start="50664490" display_stop="50747146" Strand="-" />
          </Location>
          <OMIM>609413</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000124.4(ERCC6):c.2321_2322del (p.Lys774fs)</Name>
      <CanonicalSPDI>NC_000010.11:49476274:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49476275" stop="49476276" display_start="49476275" display_stop="49476276" variantLength="2" positionVCF="49476274" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50684321" stop="50684322" display_start="50684321" display_stop="50684322" variantLength="2" positionVCF="50684320" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K774fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.50684322_50684323del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.50684322_50684323del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.49476276_49476277del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.49476276_49476277del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009442.1" sequenceAccession="NG_009442" sequenceVersion="1" change="g.67826_67827del">
            <Expression>NG_009442.1:g.67826_67827del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.4" sequenceAccession="NM_000124" sequenceVersion="4" change="c.2321_2322del" MANESelect="true">
            <Expression>NM_000124.4:c.2321_2322del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000115.1" sequenceAccession="NP_000115" sequenceVersion="1" change="p.Lys774fs">
            <Expression>NP_000115.1:p.Lys774fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346440.2" sequenceAccession="NM_001346440" sequenceVersion="2" change="c.2321_2322del">
            <Expression>NM_001346440.2:c.2321_2322del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333369.1" sequenceAccession="NP_001333369" sequenceVersion="1" change="p.Lys774fs">
            <Expression>NP_001333369.1:p.Lys774fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_465" sequenceAccession="LRG_465">
            <Expression>LRG_465:g.67826_67827del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_465t1" sequenceAccession="LRG_465t1">
            <Expression>LRG_465t1:c.2320_2321del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_465p1" sequenceAccession="LRG_465p1" change="p.Lys774Serfs">
            <Expression>LRG_465p1:p.Lys774Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000124.4(ERCC6):c.2321_2322del (p.Lys774fs) AND Cockayne syndrome type 2" Accession="RCV003883232" Version="2">
        <ClassifiedConditionList TraitSetID="433">
          <ClassifiedCondition DB="MedGen" ID="C0751038">Cockayne syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-03-05" MostRecentSubmission="2024-03-05">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="433" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1524" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cockayne Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 2</ElementValue>
                <XRef ID="MONDO:0019570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSB</ElementValue>
                <XRef Type="MIM" ID="133540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1420" />
                <XRef ID="1420" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90322" DB="Orphanet" />
              <XRef ID="C0751038" DB="MedGen" />
              <XRef ID="MONDO:0019570" DB="MONDO" />
              <XRef Type="MIM" ID="133540" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8771152" SubmissionDate="2024-02-24" DateLastUpdated="2024-03-05" DateCreated="2024-03-05">
        <ClinVarSubmissionID localKey="SUB14265812" submittedAssembly="GRCh37" title="SUB14265812" />
        <ClinVarAccession Accession="SCV004697462" DateUpdated="2024-03-05" DateCreated="2024-03-05" Type="SCV" Version="1" SubmitterName="Laboratory Cellgenetics, GMDL Cellgenetics" OrgID="508747" OrganizationCategory="laboratory" OrgAbbreviation="GMDL_CellGenetics" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6">
              <Name>ERCC excision repair 6, chromatin remodeling factor</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.50684322_50684323del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="133540" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14265812</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8771152" TraitType="Disease" MappingType="XRef" MappingValue="133540" MappingRef="OMIM">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

